According to the latest report by IMARC Group, titled “Amniotic Membrane Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global amniotic membrane market reached a value of US$ 1,290 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 2,220 Million by 2027, exhibiting a CAGR of 9.4% during 2022-2027.
Industry Overview and Application:
The amniotic membrane (AM) refers to the innermost layer of the placenta that comprises of an epithelial monolayer, an acellular intermediate basement, and an outer mesenchymal cell layer. It surrounds the embryo/fetus and delimits the amniotic cavity, which is filled with amniotic liquid and assists in healing wounds and protecting against infection. Amniotic membranes have various properties, such as anti-inflammatory, anti-bacterial, anti-viral, immunological, anti-angiogenic, proapoptotic, etc. As they interfere with tumor growth by preventing the delivery of nutrients and oxygen to cancer cells, AMs also find various applications in the field of oncology.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/amniotic-membrane-market/requestsample
The growing number of corneal surgeries due to their ability to reduce pain, improve the appearance of a diseased or damaged cornea, restore vision, etc., represents one of the key factors driving the amniotic membrane market. AMs also assist in enhancing epithelialization, maintaining epithelial phenotype, reinforcing adhesion of basal epithelial cells, etc. Furthermore, AMs are relatively cost-effective as compared to allografts and xenografts and find extensive applications in cosmetic and reconstructive surgeries. Additionally, the increasing investments in research and development (R&D) activities in the field of stem cell and regenerative are also augmenting the market growth. Besides this, rising placenta donations and the escalating demand for tissue-based products for treating surgical wounds will continue to bolster the amniotic membrane market.
Amniotic Membrane Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global amniotic membrane market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Amnio Technology LLC
- Amniox Medical Inc. (TissueTech Inc.)
- Genesis Biologics
- Human Regenerative Technologies LLC
- Integra LifeSciences Holdings Corporation
- Katena Products Inc.
- MiMedx Group
- Next Biosciences
- Skye Biologics Holdings LLC
- Smith & Nephew plc
- Surgenex LLC
- Ventris Medical LLC
- Wright Medical Group N.V. (Stryker B.V.)
Key Market Segmentation:
The report has segmented the global amniotic membrane market on the basis of product, application, end user and region.
Breakup by Product:
- Cryopreserved Amniotic Membrane
- Lyophilization Amniotic Membrane
Breakup by Application:
- Surgical Wounds
- Ophthalmology
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers and Laboratory
Breakup by Region:
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4503&flag=C
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
